Jennifer Orr, MD
Obstetrics & Gynecology · El Paso, TXNPI 1639361603
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 43 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Coloplast at 40.4% of the total. 2025 is the largest year on record at $1,668, more than ten times the $87 reported in 2019.
Across 43 payments — averaging $81.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coloplast$1K
- Boston Scientific$585
- Axonics, Inc.$555
- Medtronic$347
- Intuitive Surgical$194
- Integra Lifesciences Corporation$111
- plus $286 from 7 others
What the payments were for
- Food & beverage$3,472100%
- Education$160%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coloplast | 12 | $1,409 |
| Boston Scientific | 6 | $585 |
| Axonics, Inc. | 10 | $555 |
| Medtronic(2 entities) | 3 | $347 |
| Intuitive Surgical | 3 | $194 |
| Integra Lifesciences Corporation | 1 | $111 |
| Terumo Medical Corporation | 1 | $92 |
| Minerva Surgical, Inc | 1 | $77 |
| AstraZeneca | 2 | $42 |
| AbbVie | 1 | $29 |
| Myovant Sciences Inc. | 1 | $16 |
| Valencia Technologies Corporation | 1 | $15 |
| Dysis Medical, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,488 in reported general payments places this provider in the 75th percentile of 3,099 obstetrics & gynecology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 48 | $42,878 |
| GemtesaVibegron | 19 | $25,190 |
| Estradiol | 69 | $5,104 |
| Oxybutynin Chloride ErOxybutynin Chloride | 120 | $2,796 |
| Methenamine Hippurate | 13 | $1,267 |
| Solifenacin Succinate | 15 | $1,013 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 35 | $502 |
| Clotrimazole | 13 | $442 |
| Cephalexin | 19 | $365 |
| Ibuprofen | 42 | $268 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 33 | $193 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 19 | $190 |
| Ondansetron Hcl | 38 | $130 |
| Fluconazole | 11 | $41 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in El Paso
- Robert AsgharianEl Paso$366K
- Mario NutisEl Paso$69K
- Michiel NoeEl Paso$51K
- Devin GarzaAustin$2M
- Shawn TassoneAustin$1.3M
- Dale StovallDallas$590K
- Karyn-Anne CumberbatchMissouri City$452K
- Catherine HansenWebster$357K
- Lisa JukesBee Cave$270K
- Susan CrockettLive Oak$269K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.